Literature DB >> 10505713

Membrane-protease interactions. III: A consideration of the difference in binding potential of pancreatic proteases to erythrocytes and erythrocyte ghosts.

A S Brecher1, M Rosen, D E Burkholder.   

Abstract

Trypsin and chymotrypsin readily bind to human erythrocyte ghosts and to resealed right-side-out ghosts, but not to intact erythrocytes, as followed with [3H]trypsin and [3H]chymotrypsin and with cold proteases in a caseinolytic assay. The proteases freely reacted with casein in the presence of intact cells. Trypsin activated trypsinogen over an 8-hr time course at a faster rate in the presence of erythrocytes than in the absence thereof, after a slight initial delay. Trypsinogen did not bind to intact erythrocytes, thereby behaving comparably to trypsin. These results suggest that different microenvironments exist about the erythrocyte ghosts and the intact erythrocytes, thereby permitting the proteases to bind to the former but not to the latter. Hence, in the absence of considerable ghosts in circulating blood, which may mask the binding site of the proteases, the proteases may be more readily accessible for interaction with circulating serpins, leading to inactivation of the proteases and protection from their degradative potential. The presence of the serpins in circulating blood may assist in the control of the degradative power of the pancreatic proteases in pancreatitis and may negatively modulate such processes as thrombosis, activation of the complement system, and vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505713     DOI: 10.1023/a:1018874118683

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Acute mesenteric vein thrombosis and pancreatitis. A rare association.

Authors:  G Cornu-Labat; K Kasirajan; R Simon; D J Smith; M L Herman; J R Rubin
Journal:  Int J Pancreatol       Date:  1997-06

2.  Some studies on the effects of alpha-chymotrypsin on mast cells from the rat and other species.

Authors:  B Emadi-Khiav; F L Pearce
Journal:  Eur J Pharmacol       Date:  1996-01-11       Impact factor: 4.432

3.  [Massive recurrent gastric hemorrhage caused by thrombosis of the splenic vein in chronic pancreatitis].

Authors:  V Visokai; L Lipská
Journal:  Rozhl Chir       Date:  1995-09

4.  Acute pancreatitis and pancreatic blood flow.

Authors:  B Goodhead
Journal:  Surg Gynecol Obstet       Date:  1969-08

5.  [A case of portal vein thrombosis subsequent to acute pancreatitis].

Authors:  I Yasuda; E Tomita; Y Nishigaki; Y Ino; H Shimizu; T Yamada; H Kawamura; T Kuroda; T Takahashi; K Nagura
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1995-04

6.  A new test for the quantitative determination of chymotrypsin, chymotrypsin-like enzymes and their inhibitors.

Authors:  C E Blackwood; B F Erlanger; I Mandl
Journal:  Anal Biochem       Date:  1965-07       Impact factor: 3.365

7.  Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.

Authors:  E Kemppainen; J Hedström; P Puolakkainen; J Halttunen; V Sainio; R Haapiainen; E Kivilaakso; U H Stenman
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

8.  Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.

Authors:  M Kato; S Hayakawa; S Naruse; M Kitagawa; Y Nakae; T Hayakawa
Journal:  J Clin Lab Anal       Date:  1996       Impact factor: 2.352

9.  Modification of integrin-mediated cell attachment to substrata by serine proteinases in the presence and absence of divalent cations.

Authors:  K Fujii; G S Lazarus; N M Schechter
Journal:  Exp Cell Res       Date:  1993-09       Impact factor: 3.905

10.  Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.

Authors:  R L Kinlough-Rathbone; D W Perry; M A Packham
Journal:  Thromb Haemost       Date:  1995-01       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.